Good Samaritan Medical Center

Good Samaritan Medical Center

235 North Pearl Street, Brockton, MA 02301
508-427-3000

Print This Page Share This Page

Good Samaritan Medical Center - Site Map

(Expand All | Collapse All)

  • Home Page
  • Health & Wellness
  • Our Web Pages
  • Event Calendar
  • News Center
  • Clinical Trials
  • Physician Directory
  • *Anesthesiology
  • *Behavioral Health
  • *General Medicine
  • *General Surgery
  • *Nursing
  • *Nutrition Counseling
  • *Obstetrics/Gynecology
  • *Pathology
  • *Pharmacy
  • *Radiology
  • *Senior Behavioral Medicine Center
  • *Special Care Nursery
  • *Spiritual Care
  • *Welcome Newborn
  • Adolescent Medicine
  • Alergias y Asma
  • Alergias, Asma y Inmunología
  • Allergy and Asthma
  • Allergy and Immunology
  • Allergy, Asthma, and Immunology
  • Anesthesiology
  • Anomalías Craneofaciales
  • Arthritis and Other Rheumatic Diseases
  • Artritis y Otras Enfermedades Reumáticas
  • Artritis y Otras Enfermedades Reumáticas Pediátricas
  • Bariatric Medicine
  • Bone Disorders
  • Breast Health
  • Burns
  • Cáncer de Piel
  • Cancer Care
  • Cancer Center
  • Cardiothoracic/Thoracic Surgery
  • Cardiovascular Diseases
  • Cardiovascular Disorders
  • Cardiovascular Medicine
  • Cardiovascular Tests and Procedures
  • Care of the Terminally Ill Child
  • Caritas Good Samaritan
  • Child and Adolescent Mental Health
  • Cirugía Ortopédica
  • Cirugía Plástica
  • Clinical Trials and Research
  • Common Childhood Injuries and Poisonings
  • Complementary and Alternative Medicine
  • Content Library of Adult English Medical Content
  • Content Library of Adult Spanish Medical Content
  • Content Library of Ped English Medical Content
  • Content Library of Ped Spanish Medical Content
  • Content Library of the Cancer Center Medical Content
  • Content Library of the Heart Center Medical Content
  • Content Library of the Orthopaedic Center Medical Content
  • Content Library of the Pregnancy Center Medical Content
  • Content Library of the Women's Center Medical Content
  • Continuing Medical Education
  • Craniofacial Anomalies
  • Crecimiento y Desarrollo
  • Cuidado de Ojos
  • Cuidado de Ojos
  • Cuidado del Niño con Enfermedad Terminal
  • Cuidado Quirúrgico
  • Dental and Oral Health
  • Dermatología
  • Dermatología
  • Dermatology
  • Dermatology
  • Dermatology
  • Diabetes
  • Diabetes
  • Diabetes
  • Diabetes and Other Endocrine and Metabolic Disorders
  • Diabetes y Otros Trastornos Endocrinos y Metabólicos
  • Diagnostic Imaging
  • Digestive and Liver Disorders
  • Digestive Disorders
  • Disease and Wellness
  • Ear, Nose, and Throat
  • Embarazo de Alto Riesgo
  • Embarazo y Nacimiento
  • Embarazo y Nacimiento
  • Emergencias No-Traumáticas
  • Emergency Medicine
  • Emergency Medicine
  • Endocrinología
  • Endocrinology
  • Endocrinology
  • Endocrinology
  • Enfermedades Cardiovasculares
  • Enfermedades del Aparato Digestivo
  • Enfermedades del Hígado, Bilis y Páncreas
  • Enfermedades Infecciosas
  • Enfermedades Infecciosas
  • Environmental Medicine
  • Eye Care
  • Eye Care
  • For Professionals
  • Gastroenterology
  • Gastroenterology Tests and Procedures
  • Genética Médica
  • Genitourinary and Kidney Disorders
  • Geriatrics
  • Glossary
  • Goddard Child Care Center
  • Growth and Development
  • Gynecologic Oncology
  • Gynecological Health
  • Gynecology
  • Gynecology Tests and Procedures
  • Heart Care
  • Heart Center
  • Hematología y Enfermedades de Sangre
  • Hematología y Trastornos de Sangre
  • Hematology and Blood Disorders
  • Hematology and Blood Disorders
  • Hematology/Oncology
  • High-Risk Newborn
  • High-Risk Pregnancy
  • Home Health, Hospice, and Elder Care
  • Infectious Disease
  • Infectious Diseases
  • Infectious Diseases
  • Internal Medicine
  • Internal Medicine, Family Medicine and Primary Care
  • Kidney and Urinary System Disorders
  • Kidney Diseases
  • Lesiones y Intoxicaciones Frecuentes en Niñez
  • Liver, Biliary, and Pancreatic Disorders
  • Maternal Fetal Medicine
  • Medical Genetics
  • Medicina Complementaria Y Alternativa
  • Medicina del Adolescente
  • Medicina del Medio Ambiente
  • Medicina Física y Rehabilitacián
  • Medicina para Viajero
  • Men's Health
  • Mental Health Disorders
  • Mission & Values
  • Neonatology
  • Nephrology
  • Nervous System Disorders
  • Neurological Disorders
  • Neurological Tests and Procedures
  • Neurology
  • Neurosciences
  • Neurosurgery
  • Newsroom
  • Niño que se Somete a Cirugía
  • Non-Traumatic Emergencies
  • Normal Newborn
  • Oído, Nariz y Garganta
  • Obstetrics and Gynecology
  • Occupational Health Services
  • Oncología
  • Oncology
  • Ophthalmology
  • Oral and Maxillofacial Surgery
  • Oral Health
  • Orthopaedic Center
  • Orthopaedic Surgery
  • Orthopaedic Tests and Procedures
  • Orthopaedics
  • Orthopedic Surgery
  • Orthopedics
  • Ortopedia
  • Otolaryngology
  • Otolaryngology
  • Otorrinolaringología
  • Pain Management
  • Pain Management
  • Pathology
  • Pathology
  • Patient and Visitor Information
  • Patológica
  • Pediatría
  • Pediatric Arthritis and Other Rheumatic Diseases
  • Pediatrics
  • Pediatrics
  • Physical Medicine and Rehabilitation
  • Physical Medicine and Rehabilitation
  • Plastic Surgery
  • Plastic Surgery
  • Plastic Surgery
  • Podiatry
  • Pregnancy and Childbirth
  • Pregnancy and Childbirth
  • Pregnancy, Birth, and Baby Center
  • Prostate Health
  • Psychiatry
  • Psychiatry
  • Pulmonary Medicine and Critical Care
  • Pulmonary Tests and Procedures
  • Quality
  • Quality and Clinical Excellence
  • Quality and Patient Satisfaction
  • Quemaduras
  • Radiología
  • Radiology
  • Radiology
  • Recién Nacido de Alto Riesgo
  • Recién Nacido Normal
  • Rehabilitation & Physical Therapy Services
  • Respiratory Disorders
  • Respiratory Disorders
  • Rheumatology
  • Safety and Injury Prevention
  • Salud de Hombres
  • Salud de Mujeres
  • Salud de Prástata
  • Salud del Seno
  • Salud en Hogar, Hospicio y Cuidado de Ancianos
  • Salud Ginecológica
  • Salud Mental de Niños y Adolescentes
  • Salud Oral
  • Salud Oral y de Dientes
  • Seguridad y Prevención de Lesiones
  • Services and Clinical Centers
  • Skin Cancer
  • Sleep Medicine
  • Spine, Shoulder, and Pelvis Disorders
  • Substance Abuse
  • Surgery
  • Surgical Care
  • Tests and Procedures
  • The Child Having Surgery
  • Thoracic Surgery
  • Transplantation
  • Trasplantes
  • Trastornos Cardiovasculares
  • Trastornos de Columna Vertebral, Hombro y Pelvis
  • Trastornos de Huesos
  • Trastornos de Salud Mental
  • Trastornos del Riñón y el Aparato Urinario
  • Trastornos del Sistema Nervioso
  • Trastornos Digestivos y Hepáticos
  • Trastornos Genitourinarios y de Riñones
  • Trastornos Neurológicos
  • Trastornos Respiratorios
  • Trastornos Respiratorios
  • Travel Medicine
  • Urology
  • Urology Tests and Procedures
  • Vascular Surgery
  • Vascular Surgery
  • Ways of Giving
  • Welcome Newborn
  • Women's Center
  • Women's Health
  • Women's Health
  • Infant Loss Support Group
  • Alanon
  • Mommy & Me - Breastfeeding Support & Mothering Group
  • Alcoholics Anonymous
  • Bereavement Support Group
  • Free Cardiovascular Screenings and
  • Moody’s Investor Service Upgrades Caritas Christi Health Care System Bond Rating
  • Good Samaritan Expands Cardiac Services
  • Caritas Christi Launches Relief Effor in Haiti
  • Caritas Christi Health Care and Philips Healthcare Team Up in Significant Haiti Relief Effort
  • For Emergency Relief Workers Traveling to Haiti
  • Norwood Hospital Wins 2009 Leapfrog Award
  • Caritas Christi and 1199SEIU sign historic labor agreement to enhance care and jobs at four Massachusetts hospitals
  • Good Sam is Now Offering Valet Parking
  • Blue Cross Blue Shield of MA and Caritas Christi Healthcare Aim to Alter Healthcare Fee Model
  • Good Samaritan Lung Cancer Awareness Program to Highlight Smoking Cessation Resources
  • The Love Response
  • Good Samaritan Cardiovascular Laboratory Awarded Reaccreditation
  • Steven Gordon Appointed as President of Good Samaritan Medical Center
  • Good Samaritan Medical Center Awarded Accreditation from The Joint Commission
  • H1N1 Flu (Swine Flu) - Caritas Christi Monitoring Status
  • For Clinicians
  • Cancer Prevention with Free Screenings
  • Free Skin Cancer Screenings
  • Good Samaritan Laboratory Received Accreditation from College of American Pathologists
  • Good Samaritan was the site of a milestone knee replacement surgery: the 12,000th OtisKnee replacement.
  • Radiation Center Grand Opening
  • 2009 Mareb Lecture
  • Caritas Christi Pledges To Bring Quality To the People
  • Good Samaritan Medical Center and local agencies band together to offer residents “One Stop Shopping” for Community Benefits and Resources
  • Family Tribute Event Will Raise Money for GSMC cancer services
  • Daddy Boot Camp
  • "I Can Cope" Wellness Program
  • Caritas Christi and SEIU Reach Historic Accord
  • Caritas Christi Health Care Hospitals Honored Among Nation’s Best in Hospital Value Index Rankings
  • Good Samaritan Cancer Center
  • Caritas Good Samaritan appoints new Director of Oncology
  • Caritas Good Samaritan Medical Center welcomes Jeffrey Rediger, MD
  • Caritas Good Samaritan Occupational Health Services Medical Director honored for his contributions
  • Welcome to Ryan Frankel, MD
  • Boston Heartwalk
  • Interview with Jared Fogle
  • Prostate Cancer Screening
  • Arthur Wyman Appointed Chairman of CGSMC Board of Trustees
  • Brockton schools, health center partner for student, nursing services
  • Cancer Center Vault
  • Wound Care Center Opens at Caritas Good Samaritan Medical Center
  • New Medical Partnerships will Benefit Students & Families
  • Caritas Good Samaritan Medical Center Opens Wound Care Center
  • Elective Angioplasty
  • Gustafson Receives Award
  • Caritas Good Samaritan & The Brockton Rox Team Up to Knock Out MRSA
  • Another New Physician Joins Caritas Good Sam!
  • Caritas Good Samaritan Medical Center receives Three-Year Approval with Commendation for its Cancer Program
  • Caritas Good Samaritan Medical Center Welcomes Dr. Joel Solomon
  • Caritas Christi names Ralph de la Torre, M.D. as its president and CEO
  • Advances in Joint Replacement Highlight Community Program at Caritas Good Samaritan Medical Center
  • Female cardiologist joins Caritas Good Samaritan Medical Center and Brockton Cardiology Associates
  • Forum at Caritas Good Samaritan Medical Center to Focus on Elder Abuse
  • Peter Gordon, MD, Elected as President of Medical Staff
  • Program to Address Advances in Treatment of Varicose Veins
  • Pulmonary/Critical Care Specialist Joins Caritas Good Samaritan Medical Center
  • Winter Blues
  • Yoga for Depression
  • 64-Slice CT Scanner
  • Neonatal Partnership with Children's Hospital
  • OtisKnee Patient John Brown
  • Trinity Catholic Partnership
  • Annual Country Fair, Chicken BBQ and Safety Saturday set for Sept. 8 at Caritas Good Samaritan Medical Center
  • “Circles of Giving”- A Special Level of Giving
  • Caritas Hospice Celebrates 25 Years of Excellence
  • Children’s Bereavement Resource Center Opens in Brighton
  • Brockton Marine meets newborn daughter via video teleconferencing at Caritas Good Samaritan Medical Center
  • Children’s Hospital Boston Physicians Affiliate with Caritas Good Samaritan for Neonatology
  • When Every Second Counts in Saving a Life, Caritas Good Samaritan Medical Center Provides Critical Emergency Services
  • Hup Two Three Four: Caritas Good Samaritan Medical Center offers “boot camp” class for parents expecting twins, triplets or more
  • Caritas Good Samaritan Medical Center Hires New Director of Practice, Education and Research
  • Caritas Good Samaritan Medical Center Presents 2006 Caring With Excellence Awards
  • Caritas Good Samaritan Medical Center Cardiovascular Laboratory Receives National Accreditation
  • Caritas Good Samaritan Medical Center Intensivist Program Improves Quality and Cost Effectiveness of Caring for Critically Ill Patients
  • Pelvic Surgeon Expands OB/GYN Services At Caritas Good Samaritan Medical Center
  • Community Education & Resource Programs Gather, Sept. 9, At Caritas Good Samaritan's 17th Annual Country Fair & Safety Saturday
  • Caritas Good Samaritan Medical Center Announces 2006 Messersmith Scholars
  • Caritas Good Samaritan Medical Center Names Richard S. Herman, MD, Chair of Emergency Medicine
  • Annual Country Fair, Chicken Barbecue and Safety Saturday Slated For Sept. 9 At Caritas Good Samaritan Medical Center
  • Local Specialist In Advanced Laparoscopic Surgery Joins Caritas Good Samaritan Medical Center Medical Staff
  • Caritas Good Samaritan Medical Center Dedicates Millie Moynihan Cancer Resource Center
  • Caritas Good Samaritan Medical Center Is Only Area Hospital To Receive Certification To Perform Procedure To Unblock Neck Arteries
  • Several Caritas Good Samaritan Medical Center Physicians Have Been Included Among Best Doctors for 2006
  • Caritas Good Samaritan Medical Center Receives Grant From Yawkey Foundation
  • Paul Brown Named Executive Director of Caritas NORCAP Lodge
  • Caritas Good Samaritan Medical Center Names Barry Arkin, MD, Chief of Cardiology
  • Gov. Romney Recognizes Work For Hurricane Katrina Victims By Caritas Good Samaritan's Chairman Of Emergency Medicine
  • Caritas Good Samaritan Medical Center Offers Free Transportation Service For Cancer Patients
  • Caritas Good Samaritan Medical Center Recognizes Capital Campaign Donors
  • Caritas Good Samaritan Medical Center Presents Caring With Excellence Awards
  • "Advance for Nurses" Magazine Names Caritas Good Samaritan Medical Center's Susan Ventura, RN, 2005 Best Nurse Leader
  • Caritas Good Samaritan Medical Center Promotes DeCosta To Director of Volunteer & Guest Services
  • Caritas NORCAP Lodge Celebrates 30th Anniversary
  • Munger Named Vice President of Human Resources At Caritas Good Samaritan Medical Center
  • Caritas Good Samaritan Medical Center Receives $10,000 Grant To Gather Stroke Data
  • Elisa A. Freeman, MD, Joins Medical Staff At Caritas Good Samaritan Medical Center
  • Local Residents Receive Scholarships From Surgeon's Memorial Fund At Caritas Good Samaritan Medical Center
  • Robert Gustafson Named Chairman Of Caritas Good Samaritan Medical Center Board
  • Local Families Can Enjoy Again This Year The Country Fair, Chicken Barbecue & Safety Saturday at Caritas Good Samaritan Medical Center, Sept. 10
  • American Medical Association Names Caritas Good Samaritan One of Eight U.S. Hospitals With Exemplary Health Care Communications
  • Caritas Good Samaritan Medical Center Launches New Caritas Cardiac Catheterization Lab and Electronic Cardiology Information System
  • Caritas Good Samaritan Medical Center Announces New President
  • Caritas Good Samaritan Medical Center Chairman of Emergency Medicine Named Massachusetts College of Emergency Physicians President
  • Hoai-Nu-Thi Vo, MD, Joins Caritas Good Samaritan Medical Center Medical Staff
  • Robert Naparstek, MD, Reappointed To Commonwealth's Health Care Services Board
  • Caritas Good Samaritan Occupational Health Services Holds Injury Prevention Workshops Every Tuesday
  • Caritas Good Samaritan Medical Center Presents 2004 Caring With Excellence Awards
  • Caritas Good Samaritan Medical Center's Diagnostic Imaging Center Opens Its Doors
  • Cancer Specialist Named Director of Hematology/Oncology At Caritas Good Samaritan Medical Center
  • (CLOSURE I) A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale
  • "IMMEDIATE Trial" GLUCOSE-INSULIN-POTASSIUM (GIK) IMMEDIATE MYOCARDIAL METABOLIC ENHANCEMENT DURING INITIAL ASSESSMENT AND TREATMENT IN EMERGENCY CARE
  • 2008 Golf Tournament
  • 2008 Golf Tournament - Player Info
  • 64-Slice CT Scanner
  • A 12-Month Follow-Up Study to Protocol 24779 (A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia [ACT34-CMI])
  • A 24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis.
  • A Clinical Trial Comparing Anastrozole With Tamoxifen in Postmenopausal Patients With Ductal Carcinoma in Situ (DCIS) Undergoing Lumpectomy With Radiation Therapy
  • A Clinical Trial Comparing Preoperative Radiation Therapy And Capecitabine With or Without Oxaliplatin With Preoperative Radiation Therapy And Continuous Intravenous Infusion Of 5-Fluorouracil With or Without Oxaliplatin In The Treatment Of Patients With Operable Carcinoma Of The Rectum
  • A Clinical Trial Of Adjuvant Therapy Comparing Six Cycles Of 5-Fluorouracil, Epirubicin And Cyclophosphamide (FEC) To Four Cycles Of Adriamycin And Cyclophosphamide (AC) In Patients With Node-Negative Breast Cancer
  • A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed By an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor Positive Breast Cancer
  • A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI
  • A Double-blind, Prospective, Randomized, Placebo-controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose Range of Intramyocardial Injections of G-CSF Mobilized Auto-CD34+ Cells for Reduction of Angina Episodes in Patients With Refractory Chronic Myocardial Ischemia (ACT34-CMI)
  • A Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 1.25mg FTY720 Administered Orally Once Daily Versus Placebo in Patients With Primary Progressive Multiple Sclerosis.
  • A Double-Blind, Randomized, Placebo-Controlled Phase III Trial of Carboplatin, Paclitaxel, and BAY 43-9006 Versus Carboplatin, Paclitaxel, and Placebo in Patients With Unresectable Stage III or IV Melanoma
  • A Dual-Cohort, Prospective, Observational Study of Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer Patients With and Without Bone Metastasis
  • A Magnetic Resonance Spectroscopy and fMRI Study of the Effects of Lisdexamfetamine on Bipolar Depression
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled Staggered Dose-Escalating Phase IIb Study of the Safety and Efficacy of Istaroxime Over 24 Hours at Three Doses in Acute Decompensated Heart Failure Patients (The IGNITE Trial)
  • A multicenter, randomized, double-blind, placebo-controlled study of the effects of KW-3902 Injectable Emulsion on heart failure signs and symptoms, diuresis, renal function, and clinical outcomes in subjects hospitalized with worsening renal function and heart failure requiring intravenous therapy.
  • A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 in Patients With Intermittent Claudication
  • A Phase 3 Randomized, Rater-Blinded Study Comparing Two Annual Cycles of Intravenous Alemtuzumab to Three-Times Weekly Subcutaneous Interferon Beta-1a (Rebif®) in Treatment-Naïve Patients With Relapsing-Remitting Multiple Sclerosis
  • A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
  • A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer
  • A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy (IMRT) in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer
  • A Phase II Randomized Trial Of Surgery Followed By Chemoradiotherapy Plus Cetuximab For Advanced Squamous Cell Carcinoma Of The Head and Neck
  • A Phase II Study of Induction Chemotherapy Followed by Thoracic Radiotherapy and Erlotinib in Poor-Risk Stage III Non-Small Cell Lung Cancer
  • A Phase II Study Of Tirapazamine (NSC-130181)/Cisplatin/Etoposide And Concurrent Thoracic Radiotherapy For Limited Stage Small Cell Lung Cancer
  • A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy Plus Bevacizumab for Patients With Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor
  • A Phase II Trial of Novel Oral Anti-Angiogenic Agent AZD2171 (NSC-732208) in Malignant Pleural Mesothelioma
  • A Phase II Trial of Samarium 153 Followed by Salvage Prostatic Fossa 3DCRT or IMRT Irradiation in High-Risk, Clinically Non-Metastatic Prostate Cancer After Radical Prostatectomy
  • A Phase II/III Randomized Trial Of Two Dose Schedules For Delivering Prophylactic Cranial Irradiation For Patients With Limited Disease Small Cell Lung Cancer
  • A Phase III Biomarker Validation Study of Second-line Therapy in Patients With Advanced Non- Small Cell Lung Cancer (NSCLC) Randomized to Pemetrexed Versus Erlotinib
  • A Phase III Clinical Trial Comparing Infusional 5-Fluorouracil (5-FU), Leucovorin, and Oxaliplatin (mFOLFOX6) Every Two Weeks With Bevacizumab to the Same Regimen Without Bevacizumab for the Treatment of Patients With Resected Stages II and III Carcinoma of the Colon
  • A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently With Radiation Therapy and Radiation Therapy Alone for Women With HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
  • A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer
  • A Phase III Protocol of Androgen Suppression (AS) and 3DCRT/IMRT Vs AS and 3DCRT/IMRT Followed by Chemotherapy With Docetaxel and Prednisone for Localized, High-Risk, Prostate Cancer
  • A Phase III Randomized Double Blind Study of Vorozole Versus Placebo in Women With Primary Breast Cancer Completing Five or More Years of Adjuvant Tamoxifen
  • A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (IMC-C225) Versus Gemcitabine As First-Line Therapy Of Patients With Advanced Pancreas Cancer
  • A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Fluorouracil, Cisplatin, and Radiotherapy in Carcinoma of the Anal Canal
  • A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients With Favorable-Risk Prostate Cancer
  • A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (≤ 2 CM) Peripheral Non-Small Cell Lung Cancer
  • A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate Risk Prostatic Carcinoma
  • A Phase III Study of the Addition of Gemtuzumab Ozogamicin (Mylotarg®) During Induction Therapy Versus Standard Induction With Daunomycin and Cytosine Arabinoside Followed by Consolidation and Subsequent Randomization to Post-Consolidation Therapy With Gemtuzumab Ozogamicin (Mylotarg®) or No Additional Therapy For Patients Under Age 61 With Previously Untreated De Novo Acute Myeloid Leukemia (AML)
  • A Phase III Trial of CHOP Plus Rituximab vs CHOP Plus Iodine-131-Labeled Monoclonal Anti-B1 Antibody (Tositumomab) for Treatment of Newly Diagnosed Follicular Non-Hodgkin's Lymphomas
  • A Phase III Trial of Concurrent Radiation and Chemotherapy for Advanced Head and Neck Carcinomas
  • A Phase III Trial of Irinotecan / 5-FU / Leucovorin or Oxaliplatin / 5-FU/ Leucovorin With Bevacizumab, or Cetuximab (C225), or With the Combination or Bevacizumab and Cetuximab for Patients With Untreated Metastatic Adenocarcinoma of the Colon or Rectum
  • A Phase III Trial of Short Term Androgen Deprivation With Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients With a Rising PSA After Radical Prostatectomy
  • A Phase III, Open-Label Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters
  • A Phase IIIb, randomized, double blind, parallel-group, multi-center study to assess the efficacy and safety of multiple 30-minute infusions of Conivaptan in subjects with euvolemic or hypervolemic hyponatremia
  • A Pilot (Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor Risk Stage III Non-Small Cell Lung Cancer
  • A pilot study evaluating the safety of avastin and pelvic radiation in women with pelvic-confined recurrence of gynecological cancers
  • A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Addition of Bevacizumab (NSC-704865) in Three Cohorts of Patients With Inoperable Locally Advanced Stage III Non-Small Cell Lung Cancer
  • A pivotal study to evaluate the effectiveness and safety of ExAblate treatment of metastatic bone tumors for the palliation of pain in patients who are not candidates for radiation therapy
  • A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation
  • A Prospective, Randomized, Double-blind, Stratified, Multi-center, 2-arm Trial of the Continued Efficacy and Safety of Zoledronic Acid (Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Breast Cancer
  • A Prospective, Randomized, Multicenter, Open Label, Pilot Study to Evaluate the ROX Anastomotic Coupler System in Patients With Chronic Obstructive Pulmonary Disease
  • A Randomized Controlled Trial of Radiofrequency Ablation for the Treatment of Paroxysmal Atrial Fibrillation Using the Bard High Density Mesh Ablation System (MAGELLAN)
  • A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients With Advanced Transitional Cell Carcinoma
  • A Randomized Phase II Study of Radiation Therapy, Pemetrexed and Carboplatin With or Without Cetuximab in Stage III Non-Small Cell Lung Cancer
  • A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin Versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients With Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
  • A randomized phase III trial of neoadjuvant therapy for patients with palpable and operable HER-2 positive breast cancer comparing the combination of trastuzumab plus lapatinib to trastuzumab and to lapatinib administered with weekly paclitaxel following AC accompnied by correlative science studies to identify predictors of pathologic complete response
  • A Randomized Trial of Adjuvant Chemotherapy With Standard Regimens, Cyclophosphamide, Methotrexate and Fluorouracil - (CMF) or Doxorubicin and Cyclophosphamide - (AC), Versus Capecitabine in Women 65 Years and Older With Node Positive or Node-Negative Breast Cancer
  • A Randomized, Double-Blind, Placebo Controlled, Cross-over Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Multifocal Motor Neuropathy
  • A Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Multi-Center Study of Eculizumab in Patients With Generalized Myasthenia Gravis (gMG) Who Have Moderate to Severe Muscle Weakness Despite Treatment With Immunosuppressants
  • A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Anamorelin HCl Dose Range Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients With NSCLC
  • A Randomized, Double-Blind, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab Therapy With or Without Erlotinib After Completion of Chemotherapy With Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer
  • A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Dose-Comparison Study to Determine the Efficacy and Safety of BG00012 in Subjects with Relapsing-Remitting Multiple Sclerosis
  • A Randomized, Prospective, Double-Blinded, Placebo-Controlled (Sham-Controlled) Study to Evaluate the Safety and Effectiveness of the Adacolumn Apheresis System for the Treatment of Moderate to Severe Ulcerative Colitis
  • A Randomized, Single-blind, Placebo-controlled, 4-Week Treatment Study of the Safety and Biologic Activity of Escalating Multiple Oral Doses of FG-4592 in Subjects with Chronic Kidney Disease Not Requiring Dialysis
  • A Randomized, Single-blind, Placebo-controlled, 4-Week Treatment Study of the Safety and Biologic Activity of Escalating Multiple Oral Doses of FG-4592 in Subjects with Chronic Kidney Disease Not Requiring Dialysis
  • A Statewide Partnerships for Worksite Weight Management Grant Project
  • A World of Volunteer Opportunities
  • About Us: History
  • About Us: Living Our Values
  • About Us: Marketing Code of Ethics
  • About Us: Portuguese
  • Accupuncture
  • Active Parenting
  • Adjuvant 3DCRT/IMRT in Combination With Androgen Suppression and Docetaxel for High Risk Prostate Cancer Patients Post-Prostatectomy: A Phase II Trial
  • An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Cancer and Locally Advanced or Metastatic Non-Small Cell Lung (Excluding Predominant Squamous Cell Histology)
  • An Open-Label, Multicenter Study to Determine Subject Satisfaction in Using the Single-Use Autoinjector with a Pre-Filled Liquid Avonex® Syringe in Multiple Sclerosis
  • Anesthesiology
  • Annual Fund
  • AVAIL CLS/CRT: AV-Node Ablation With CLS and CRT Pacing Therapies for the Treatment of AF
  • Blood Drive
  • Breaking News
  • Breast Cancer Services
  • Breast Imaging Center
  • Breastfeeding Class for Returning to Work
  • Breastfeeding Prenatal Class
  • CALGB 10603: A Phase III Randomized, Double-Blind Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy + Midostaurin (PKC412) (IND #101261) or Placebo in Newly Diagnosed Patients < 60 Years of Age With FLT3 Mutated Acute Myeloid Leukemia (AML)
  • CALGB 80101 Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
  • Cancer Care
  • Cancer Care Physicians
  • Cancer Support Group
  • Cardiac Rehabilitation
  • Cardiology
  • Careers
  • Careers - Current Openings
  • Careers - Disagree
  • Careers - Mission and Values
  • Careers - To Do
  • Caritas Good Samaritan Cancer Center
  • Carotid Revascularization Endarterectomy vs Stenting Trial (CREST)
  • Carotid Revascularization with ev3 Arterial Technology Evolution Post Approval Study (CREATE PAS)
  • Carotid Stenting for High Surgical-Risk Patients: Evaluating Outcomes Through the Collection of Clinical Evidence (“CHOICE”)
  • Childbirth Education at Good Samaritan Medical Center
  • Chronic Pain Support Group
  • Chronic Patient Resolution Program
  • Cisplatin, Irinotecan and Bevacizumab (NSC #704865, IND #7921) for Untreated Extensive Stage Small Cell Lung Cancer: A Phase II Study
  • Clinical Pastoral Education
  • Clinical Trials and Research
  • Clinical Trials and Research Display
  • Clinical Trials and Research Listing
  • Clinical Wizards
  • CME - Fever of Unknown Origin in the Critically Ill
  • Community Education - Minimally Invasive Treatment of Varicose Veins
  • Community Health Education - Kidney Stones - Kidney Cancer
  • Comparison of the SUpera® PERipheral System to a Performance Goal Derived From Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery
  • Comparison of the SUpera® PERipheral System to a Performance Goal derived from Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery (The SUPERB Study) Carotid Trial
  • Condition Index
  • CONSERV-1 (Clinical Outcomes and Safety Trial to Investigate Ecallantide's Effect on Reducing Surgical Blood Loss Volume) A Phase 2 Randomized Placebo-controlled Dose-ranging Study in Subjects Exposed to Cardio-pulmonary Bypass During Primary Coronary Artery Bypass Graft Surgery
  • Contact Us
  • Contacts
  • Continence / Pelvic Floor Services
  • Continuing Medical Education
  • Coral: Cardiovascular Outcomes in Renal Atherosclerotic Lesions Randomized and Multi-Center Two-Group Clinical Trial to Assess the Best Treatment for Patients with High Blood Pressure and Renal Artery Stenosis: Stenting with Anti-Hypertensive Medical Therapy Compared to Medical Therapy Alone
  • Country Fair and Chicken Barbecue
  • CPR for Friends & Family
  • CPR Heartsaver Course
  • CT Scan
  • Cyclophosphamide And Doxorubicin (CA) (4 VS 6 Cycles) Versus Paclitaxel (4 VS 6 Cycles) As Adjuvant Therapy For Breast Cancer in Women With 0-3 Positive Axillary Lymph Nodes:A 2X2 Factorial Phase III Randomized Study
  • Cytogenetic Studies in Leukemia Patients
  • Cytokine and Neutrophil Gene Polymorphisms: Novel Predictors of Acute Renal Failure Following Cardiac Pulmonary Bypass
  • Cytokine Gene Polymorphisms in Acute Renal Failure
  • Daddy Boot Camp
  • DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation
  • Diabetes
  • Diagnostic Imaging
  • Dialysis Support Group
  • Digital Mammography Services
  • Directions
  • Directions: Caritas Norcap Lodge
  • Directions: Conference Rooms
  • Directions: Printer Friendly Directions
  • Disclaimer
  • Disease & Wellness
  • Docetaxel plus 6-month androgen suppression and radiation therapy versus 6-month androgen suppression and radiation therapy for patients with high-risk localized or locally advanced prostate cancer: A randomized controlled trial
  • Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure (ASCEND-HF)
  • During Your Stay
  • DX-88 (Ecallantide) for the Reduction of Blood Loss Associated With Cardiopulmonary Bypass: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study in Patients Undergoing Primary Coronary Artery Bypass Grafting, Single Valve Repair or Single Valve Replacement
  • E1505 A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB-IIIA Non-Small Lung Cancer (NSCLC)
  • E2805: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
  • E5103: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
  • Electrophysiology
  • Email A Patient
  • Emergency Medicine
  • Emotions Anonymous
  • Endocrine Therapy With or Without Inhibition of EGF and HER2 Growth Factor Receptors: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib (GW572016) for Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer
  • Endocrinology
  • Ergonomics and Injury Prevention Educational Programs
  • Evaluating the Use of the FiberNet® Embolic Protection System in Carotid Artery Stenting: The EPIC US Pivotal Study
  • Extension to CFTY720D2309 (24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod [FTY720] Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis [RRMS])
  • Feasibility Study of a Behavioral Intervention for Women at Persistent High Risk for HIV Infection
  • Fitness for Duty Evaluation
  • Flu Season Alert
  • For Clinicians - No Content - To Do
  • For Professionals
  • For Professionals - No Content - To Do
  • Free Cardiovascular Screening and Health Assessment
  • Free Care
  • Free Prostate Cancer Screening
  • Fundraising Events
  • General Medicine
  • Genetic Analysis of Patients With Pseudoxanthoma Elasticum (PXE)
  • Geriatrics
  • Gift Planning
  • Giving Clubs
  • Good Samaritan Awarded Joint Commission Accreditation
  • Good Samaritan Cancer Center Virtual Tour
  • Gore Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (GORE EMBOLDEN)
  • Gore Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (Gore Embolden) Protocol GEF-06-08
  • Gore Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease (VIPER)
  • Gynecology Services
  • H1N1 Flu (Swine Flu) - What You Need to Know
  • Haiti Relief Efforts
  • Health Library
  • Healthcare Provider Initial CPR Course
  • Hearing Conservation Program
  • Heart Care
  • Heartsaver Adult Initial or Retrain CPR Course
  • Heartsaver Pedi Initial or Retrain CPR Course
  • Hematology
  • Honor Gift
  • Hospitalist Program
  • How to Apply
  • How To Receive a Copy of Your Medical Record
  • How You Can Help: Make a Donation
  • Induction Cisplatin/Irinotecan Followed By Combination Carboplatin, Etoposide And Chest Radiotherapy In Limited Stage Small Cell Lung Cancer: A Phase II Study
  • Infant CPR and First Aid
  • Injection of Autologous CD34-Positive Cells for Neovascularization and Symptom Relief in Patients With Myocardial Ischemia
  • Insulin Resistance Intervention After Stroke (IRIS) Trial
  • Interactive Tools & Resources
  • Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving Pre-Operative Chemoradiation
  • Internal Medicine
  • Interpreter Services
  • Job Fair
  • Join Others Who Support Us
  • Keeping Well in Mind, Body and Spirit: I Can Cope
  • Kidney Diseases
  • Leukemia Centralized Reference Laboratories and Tissue Repositories - Ancillary
  • Living Inside Hope Dinner Dance
  • Loss Prevention Programs
  • Lung Cancer Specimen Repository Protocol, Ancillary
  • Main Page
  • Make a Donation
  • Managing a Patient on Heparin
  • MASS COMM TRIAL- A randomized trial to Compare Percutaneous Coronary Intervention Between Massachusetts Hospital with Cardiac Surgery-On-Site and Community Hospital without Cardiac Surgery-On-Site.
  • Maternity Services
  • Media Coverage
  • Medical Records & Billing
  • Memorial Gift
  • Mission and Values
  • Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
  • Mom, Dad, Can We Talk?
  • Mother's Breast Pumping Class
  • Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subjects with Euvolemic Hyponatremia
  • Natural Family Planning
  • NECN Coverage of Caritas Christi Relief Team Departing For Haiti
  • Neonatology
  • Neurosciences
  • News Releases
  • News Via RSS
  • Newsletter
  • Newsletter Removal
  • Newsletter Signup
  • Newsletter Signup
  • Newsletter Unsubcribe
  • NewsRoom
  • NO147: A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) With or Without Cetuximab (C225) After Curative Resection for Patients With Stage III Colon Cancer
  • Notes from the Field
  • Nuclear Medicine
  • Nursing
  • Nutrition During Cancer Treatment
  • Nutrition Services
  • OccDocOnline
  • Occupational Health Services
  • Orthopedics
  • OtisKnee
  • Our Newsletter
  • Our Physicians
  • Our System - No Content - To Do
  • Overeaters Anonymous
  • p.VGI.1 (VEGF2) Gene Transfer for Diabetic Neuropathy
  • Pain Management
  • Pain Management Services
  • Parenting Multiples Boot Camp
  • Parenting Support Group
  • Pathology
  • Patient Accounts & Billing
  • Patient Advocates
  • Patient and Visitor Information
  • Patient Rights
  • Patient Safety
  • Patient Satisfaction Survey
  • Pediatric Quality of Life Among Population With BMI Greater Than or Equal to 85%: Impact of a Behavioral Intervention Program
  • PET Scan
  • Pharmacy
  • Phase 1 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Heterogeneous Emphysema
  • Phase 1 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema
  • Phase 2 Study of the Biologic Lung Volume Reduction System (BLVR) in Patients With Advanced Upper Lobe Predominant Emphysema
  • Phase 3 Randomized, Rater- and Dose-Blinded Study Comparing 2 Annual Cycles of IV 12 mg and 24 mg Alemtuzumab to 3x Weekly SC Interferon Beta-1a (Rebif®) in Relapsing-Remitting Multiple Sclerosis Patients Who Have Relapsed on Therapy
  • Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Patients With Advanced Upper Lobe Predominant Emphysema
  • Phase II Evaluation of Aprepitant, Dexamethasone, and Palonosetron as Antiemetic Therapy in Breast Cancer Patients Receiving Doxorubicin in Combination with Cyclophosphamide
  • Phase II study of Docetaxel and atrasentan versus docetaxel and placebo for patients with advanced hormaone refractory prostate cancer.
  • Phase II Trial of Androgen Suppression for 6 Months Combined With External Beam Radiotherapy (EBRT) With Brachytherapy (BT) Boost for Intermediate Risk Prostate Cancer
  • Phase II Trial of Simple Oral Therapy (Continuous Oral Cyclophosphamide and Capecitabine) in Patients With Metastatic Breast Cancer
  • Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck
  • Phase III Chemoprevention Trial Of Selenium Supplementation In Persons With Resected Stage I Non-Small Cell Lung Cancer
  • Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
  • Phase III Randomized Study of TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Liposomal Doxorubicin (Doxil) as Second-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer [ASSIST-3]
  • Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer
  • Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
  • Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer
  • Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
  • Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus RT for Good Risk Duct Carcinoma In-Situ (DCIS) of the Female Breast
  • Pivotal/Phase III Multicentered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 Solution (Zuragen), and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis
  • Plastic Surgery
  • Prepared Childbirth Classes
  • Preparing for Your Stay
  • Priority Giving Projects
  • Privacy Policy
  • Prospective Evaluation of Elastic Restraint to LESSen the Effects of Heart Failure (PEERLESS-HF) Trial
  • Prospective Evaluation of the Incidence of Nausea and Vomiting in Patients With Colorectal Cancer Receiving Irinotecan-Based Therapy
  • Prostate Cancer Screening
  • Prostate Education and Awareness Program
  • PROTECTed Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA)
  • Psychiatry
  • Quality and Clinical Excellence
  • Quality and Patient Satisfaction
  • Quality of Life, Employment and Informal Care Cost Analysis in Women Receiving Adjuvant Chemotherapy for Breast Cancer With 0-3 Positive Axillary Lymph Nodes
  • RADIANT: A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Single-agent Tarceva® (Erlotinib) Following Complete Tumor Resection With or Without Adjuvant Chemotherapy in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma Who Have EGFR-positive Tumors
  • RADIANT: Phase II Trial Of OSI-774 (NSC-718781) In Patients With Advanced Non-Small Cell Lung Cancer And A Performance Status Of 2
  • Radiation Oncology Pics - April 15
  • Radiation Oncology Pics - April 30
  • Radiation Oncology Pics - July, 2008
  • Radiation Oncology Pics - June, 2008
  • Radiation Oncology Update Pictures
  • Radiation Oncology Updates
  • Radiation Therapy
  • Randomized Placebo-Controlled Trial of Acetyl-L-Carnitine (ALC) for the Prevention of Taxane Induced Neuropathy Phase III
  • Refresher Prepared Childbirth Class
  • Rehabilitation & Physical Therapy
  • Revised Protocol 07 to Protocol CA225006 - A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Carcinoma
  • Senior Behavioral Medicine Center
  • Senior Leadership Team
  • Services and Clinical Centers Home
  • Skin Cancer Screening
  • Sleep Medicine Services
  • Smoker's Quit Line
  • Smoking Cessation Program
  • Smoking Cessation Support Group
  • SO720: Phase II ERCC1 and RRM1-Based Adjuvant Therapy Trial in Patients With Stage I Non-Small Cell Lung Cancer (NSCLC)
  • SO819: A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
  • Social Services
  • SONOMA: The NexStentâ Carotid Stent System: A Post Market Approval Evaluation Study in conjunction with the Boston Scientific FilterWire EZ Embolic Protection System
  • Special Care Nursery
  • Spiritual Care
  • Spiritual Care
  • Stenting and Angioplasty with Protection in Patients at High-Risk For Endarterectomy-Sapphire WW (Protocol# P06-3603)
  • Stroke Services
  • Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer
  • Substance Abuse
  • Substance Abuse Testing Services
  • Surgery
  • Sustaining Cessation in Smokers With Kids With Asthma
  • TAILORx: Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning Individualized Options for Treatment: The TAILORx Trial
  • Teen Prepared Childbirth (18 years old & younger)
  • Test
  • Test
  • Testimonials
  • Testimonials: "Thank You" and "Kudo"
  • Testimonials: Blessed with Twins on Thanksgiving
  • Testimonials: Exceptional Care
  • Testimonials: Highly Skilled ICU Nurses
  • Testimonials: Sincerely Grateful
  • Testimonials: Thanks Doctor
  • Testimonials: Thanks For Making Me Comfortable
  • Testimonials: The Staff Raises "the bar" as Far as Proffesionalism and Dedication
  • Testimonials: Ultrasound Unit - Keep up the Outstanding Work
  • Tests & Procedures
  • Tests & Procedures List
  • Thank You
  • The Breast Imaging Center
  • The Effect of Vaginal Progesterone Administration in the Prevention of Preterm Birth in Women With a Short Cervix [Vaginal Progesterone Bioadhesive Gel (Prochieve)® Extending Gestation A New Therapy for Short Cervix - Trial (PREGNANT Short Cervix - Trial)]
  • The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Co-morbid Anxiety and Insomnia: A Proton MRS Study
  • The Friends
  • The Harbinger ICD Patient (HIP) Study
  • The NexStent® Carotid Stent System: A Post Market Approval Evaluation Study In Conjunction With the FilterWire EZ™ Embolic Protection System
  • Thoracic Surgery
  • To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter
  • Travel Clinic
  • Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
  • Tribute Gifts
  • Type 2 Diabetes and Obesity Pediatric Prevention Project
  • Ultrasound
  • Upcoming Events
  • Validation of Serum Markers as a Bioassay for Unipolar Depression
  • Vascular Surgery
  • VEGF Gene Transfer for Critical Limb Ischemia
  • Visitors
  • Volunteer Your Time
  • Walk Through Available
  • Wall of Hope & Tribute
  • Ways of Giving
  • Welcome Newborn
  • Welcome Newborn Enter Site TO DO
  • Welcome Newborn Home
  • What's New at Caritas Good Samaritan
  • When You Leave
  • Women's Health
  • Work Hardening Program
  • World-Class Cancer Care Is A Team Effort
  • Wound Care & Hyperbaric Medicine
  • Yoga Classes
  • Yoga for Depression: The Ancient Approach to Inner Peace

Site Map | Disclaimer | Privacy Policy | Contact Us

Copyright © 2010 Caritas Christi